{
  "section_id": "lung",
  "subsection_id": "obstructive",
  "title": "انسدادی (آسم/COPD)",
  "questions": [
    {
      "id": 1,
      "q": "بیمار ۴۲ ساله با تنگی نفس تکراری و سیاق حساسیت. اسپیرومتری: FEV₁ ۶۵% predicted، FEV₁/FVC ۰.۶۲، بهبودی ۲۲% بعد از bronchodilator. تشخیص احتمالی چیست؟",
      "options": [
        "Mild persistent asthma",
        "COPD with air trapping",
        "Restrictive pattern",
        "Normal spirometry with exercise-induced symptoms"
      ],
      "correct": 0,
      "analysis": {
        "options": [
          "FEV₁/FVC <۰.۷ = obstructive pattern",
          "Bronchodilator response >۱۲% + ۲۰۰ mL = asthma",
          "FEV₁ ۶۵% = mild obstruction",
          "Restrictive: FVC کاهش first"
        ],
        "points": [
          "Asthma: reversibility به bronchodilator >۱۲%",
          "FEV₁ ۶۵%: mild-to-moderate severity",
          "History + reversibility: asthma diagnosis"
        ]
      },
      "difficulty": "medium",
      "tags": ["asthma", "spirometry", "bronchodilator response", "reversibility"],
      "reference": "GINA Asthma Diagnosis and Spirometry Criteria"
    },
    {
      "id": 2,
      "q": "بیمار ۶۸ ساله سیگاری ۳۰ سال. Spirometry: FEV₁ ۴۵% predicted، FEV₁/FVC ۰.۵۸، bronchodilator response ۸%. کدام stage COPD است؟",
      "options": [
        "GOLD Stage 1 (Mild)",
        "GOLD Stage 2 (Moderate)",
        "GOLD Stage 3 (Severe)",
        "GOLD Stage 4 (Very Severe)"
      ],
      "correct": 2,
      "analysis": {
        "options": [
          "Stage 1: FEV₁ ≥۸۰%",
          "Stage 2: FEV₁ ۵۰-۷۹%",
          "Stage 3: FEV₁ ۳۰-۴۹%",
          "Stage 4: FEV₁ <۳۰%"
        ],
        "points": [
          "GOLD staging: بر اساس FEV₁ میزان",
          "FEV₁ ۴۵% = Stage 3 (Severe)",
          "Limited reversibility: COPD نه asthma"
        ]
      },
      "difficulty": "easy",
      "tags": ["COPD", "GOLD classification", "spirometry", "FEV1"],
      "reference": "GOLD COPD Classification 2024"
    },
    {
      "id": 3,
      "q": "خانم ۳۵ ساله با asthma exacerbation شدید. Peak expiratory flow (PEF) ۴۰% predicted، stridor، altered speech. کدام اقدام فوری است؟",
      "options": [
        "Systemic corticosteroid + SABA آئروسول",
        "Oxygen + systemic steroid + SABA + ipratropium IV",
        "Magnesium sulfate IV + oxygen + steroid + SABA",
        "Urgent intubation"
      ],
      "correct": 2,
      "analysis": {
        "options": [
          "SABA + steroid: mild-to-moderate exacerbation",
          "Ipratropium: added برای severe",
          "Magnesium: refractory exacerbation کمک می‌کند",
          "Intubation: اگر altered mental + fatigue"
        ],
        "points": [
          "Severe asthma exacerbation: combined approach",
          "Magnesium sulfate: clinical benefit refractory cases",
          "PEF <۴۰%: hospitalization + intensive therapy"
        ]
      },
      "difficulty": "hard",
      "tags": ["asthma exacerbation", "severe", "magnesium", "emergency"],
      "reference": "GINA Acute Asthma Exacerbation Management"
    },
    {
      "id": 4,
      "q": "بیمار ۵۵ ساله COPD with FEV₁ ۴۸% predicted، مناسب برای کدام stepwise therapy؟",
      "options": [
        "LAMA یا LABA تکی",
        "LABA + ICS combination",
        "LAMA + LABA (dual therapy)",
        "Triple therapy (LAMA + LABA + ICS)"
      ],
      "correct": 2,
      "analysis": {
        "options": [
          "Single: FEV₁ ۶۰-۸۰%",
          "LABA + ICS: اگر exacerbations recurring",
          "LAMA + LABA: FEV₁ <۵۰% یا recurrent exacerbation",
          "Triple: اگر exacerbation severe/recurrent"
        ],
        "points": [
          "GOLD stepwise: FEV₁ based + exacerbation history",
          "FEV₁ ۴۸%: moderate-to-severe obstruction",
          "Dual bronchodilator: standard برای این level"
        ]
      },
      "difficulty": "medium",
      "tags": ["COPD", "stepwise therapy", "LAMA", "LABA", "FEV1"],
      "reference": "GOLD COPD Pharmacological Management"
    },
    {
      "id": 5,
      "q": "بیمار ۶۲ ساله COPD exacerbation with PaO₂ ۶۲ mmHg (oxygen ۲L/min). تاریخ سیگار ۴۰ سال. کدام درمان oxygen strategy درست است؟",
      "options": [
        "Target SpO₂ ۹۸-۱۰۰% برای بهترین oxygenation",
        "Target SpO₂ ۹۰-۹۴% برای جلوگیری CO₂ retention",
        "Target SpO₂ ۸۸-۹۲% برای دوام respiratory drive",
        "Target SpO₂ >۹۵% برای safety margin"
      ],
      "correct": 1,
      "analysis": {
        "options": [
          "۹۸-۱۰۰%: hypoxia over-correction و CO₂ retention risk",
          "۹۰-۹۴%: balance oxygenation + preserve drive",
          "۸۸-۹۲%: too low برای exacerbation acute",
          ">۹۵%: contraindicated COPD with CO₂ sensitivity"
        ],
        "points": [
          "COPD + CO₂ retention: cautious oxygen approach",
          "Target SpO₂ ۹۰-۹۴%: guideline-recommended",
          "Over-oxygenation: removes respiratory stimulus"
        ]
      },
      "difficulty": "hard",
      "tags": ["COPD exacerbation", "oxygen therapy", "CO2 retention", "hypercapnia"],
      "reference": "COPD Exacerbation Oxygen Management Guidelines"
    },
    {
      "id": 6,
      "q": "بیمار ۷۰ ساله Alpha-1 antitrypsin deficiency (بدون smoking history). تصویر: basilar-predominant emphysema. Spirometry: FEV₁ ۵۲% predicted. درمان مناسب؟",
      "options": [
        "Bronchodilators + smoking cessation",
        "Bronchodilators + Alpha-1 protease inhibitor replacement",
        "ICS + LABA برای سوزاندن رشد",
        "Lung transplantation immediate"
      ],
      "correct": 1,
      "analysis": {
        "options": [
          "Smoking cessation: standard لکن Alpha-1 needs replacement",
          "Alpha-1 replacement: slows decline significantly",
          "ICS: not primary therapy برای Alpha-1",
          "Transplantation: FEV₁ <۲۵% و symptomatic hypercapnia"
        ],
        "points": [
          "Alpha-1 deficiency: unique diagnosis و treatment",
          "Replacement therapy: proven benefit progression",
          "FEV₁ ۵۲%: eligible برای Alpha-1 therapy"
        ]
      },
      "difficulty": "hard",
      "tags": ["Alpha-1 antitrypsin deficiency", "replacement therapy", "emphysema"],
      "reference": "Alpha-1 Antitrypsin Deficiency Management"
    },
    {
      "id": 7,
      "q": "بیمار ۴۵ ساله mild asthma with GINA step ۲ (need controller). کدام بهترین initial controller است؟",
      "options": [
        "Low-dose ICS",
        "LTRA (montelukast)",
        "Long-acting beta-2 agonist (LABA) تکی",
        "Theophylline"
      ],
      "correct": 0,
      "analysis": {
        "options": [
          "Low-dose ICS: first-line gold standard",
          "LTRA: alternative اگر ICS contraindicated",
          "LABA: never monotherapy، always with ICS",
          "Theophylline: outdated، adverse profile"
        ],
        "points": [
          "GINA Step 2: low-dose ICS preferred",
          "ICS efficacy: superior به alternatives",
          "Timing: daily regular use، not PRN"
        ]
      },
      "difficulty": "medium",
      "tags": ["asthma", "GINA step 2", "ICS", "low-dose controller"],
      "reference": "GINA Asthma Step-wise Treatment Approach"
    },
    {
      "id": 8,
      "q": "بیمار ۵۸ ساله COPD + asthma overlap. FEV₁ ۵۰% predicted، reversibility ۲۰%، smoking history ۲۵ سال. درمان مناسب؟",
      "options": [
        "LAMA + LABA + low-dose ICS",
        "LAMA + LABA (بدون ICS)",
        "High-dose ICS monotherapy",
        "Triple therapy with high-dose ICS"
      ],
      "correct": 0,
      "analysis": {
        "options": [
          "LAMA + LABA + low-dose ICS: appropriate mixture",
          "Dual برای pure COPD لکن asthma features حاضر",
          "ICS monotherapy: inadequate bronchodilation",
          "High-dose ICS: may excess اگر asthma limited"
        ],
        "points": [
          "ACO (Asthma-COPD Overlap): ICS beneficial",
          "Reversibility ۲۰%: asthma component present",
          "Triple with low-dose ICS: optimal ترکیب"
        ]
      },
      "difficulty": "hard",
      "tags": ["asthma-COPD overlap", "ACO", "triple therapy", "ICS"],
      "reference": "Asthma-COPD Overlap Syndrome Management"
    },
    {
      "id": 9,
      "q": "بیمار ۵۲ ساله COPD with frequent exacerbation (۴ exacerbation/سال). Current therapy: LAMA + LABA. کدام اضافه شود؟",
      "options": [
        "Roflumilast (phosphodiesterase-4 inhibitor)",
        "Low-dose ICS",
        "High-dose ICS",
        "Theophylline"
      ],
      "correct": 0,
      "analysis": {
        "options": [
          "Roflumilast: reduces exacerbation frequency",
          "Low-dose ICS: اگر eosinophil >۱۰۰",
          "High-dose ICS: overkill اگر no asthma",
          "Theophylline: obsolete"
        ],
        "points": [
          "Frequent exacerbation: roflumilast indication",
          "Roflumilast: PDE4 inhibitor reduce inflammation",
          "Dual bronchodilator + roflumilast: standard"
        ]
      },
      "difficulty": "hard",
      "tags": ["COPD exacerbation", "roflumilast", "frequent exacerbation"],
      "reference": "Roflumilast in COPD Management"
    },
    {
      "id": 10,
      "q": "بیمار ۶۵ ساله with COPD exacerbation and acute cor pulmonale. RV dilatation visible، elevated JVP. Oxygen بدون کنترل تنگی نفس. کدام عامل مقصر است؟",
      "options": [
        "Excessive oxygen causing CO₂ narcosis + hypoventilation",
        "Underlying pneumonia deteriorating",
        "Acute PE superimposed",
        "Myocardial infarction"
      ],
      "correct": 0,
      "analysis": {
        "options": [
          "Oxygen: removes hypoxic stimulus → CO₂ rise",
          "Pneumonia: present لکن oxygen not cause",
          "PE: possible لکن less likely context",
          "MI: possible لکن oxygen not direct cause"
        ],
        "points": [
          "COPD + high-flow oxygen: CO₂ narcosis risk",
          "Cor pulmonale: manifestation RV strain",
          "Appropriate oxygen titration: SpO₂ ۹۰-۹۴%"
        ]
      },
      "difficulty": "hard",
      "tags": ["COPD exacerbation", "cor pulmonale", "CO2 narcosis", "oxygen"],
      "reference": "COPD Exacerbation Hypercapnia Management"
    }
  ]
}
